Document Type
Article
Publication Date
8-1-2023
Abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with excess risk of cardiovascular and thrombotic events in the early post-infection period and during convalescence. Despite the progress in our understanding of cardiovascular complications, uncertainty persists with respect to more recent event rates, temporal trends, association between vaccination status and outcomes, and findings within vulnerable subgroups such as older adults (aged 65 years or older), or those undergoing hemodialysis. Sex-informed findings, including results among pregnant and breastfeeding women, as well as adjusted comparisons between male and female adults are similarly understudied.
METHODS: Adult patients, aged ≥18 years, with polymerase chain reaction-confirmed COVID-19 who received inpatient or outpatient care at the participating centers of the registry are eligible for inclusion. A total of 10,000 patients have been included in this multicenter study, with Brigham and Women's Hospital (Boston, MA) serving as the coordinating center. Other sites include Beth Israel Deaconess Medical Center, Anne Arundel Medical Center, University of Virginia Medical Center, University of Colorado Health System, and Thomas Jefferson University Health System. Data elements will be ascertained manually for accuracy. The two main outcomes are 1) a composite of venous or arterial thrombotic events, and 2) a composite of major cardiovascular events, defined as venous or arterial thrombosis, myocarditis or heart failure with inpatient treatment, new atrial fibrillation/flutter, or cardiovascular death. Clinical outcomes are adjudicated by independent physicians. Vaccination status and time of inclusion in the study will be ascertained for subgroup-specific analyses. Outcomes are pre-specified to be reported separately for hospitalized patients versus those who were initially receiving outpatient care. Outcomes will be reported at 30-day and 90-day follow-up. Data cleaning at the sites and the data coordinating center and outcomes adjudication process are in-progress.
CONCLUSIONS: The CORONA-VTE-Network study will share contemporary information related to rates of cardiovascular and thrombotic events in patients with COVID-19 overall, as well as within key subgroups, including by time of inclusion, vaccination status, patients undergoing hemodialysis, the elderly, and sex-informed analyses such as comparison of women and men, or among pregnant and breastfeeding women.
Recommended Citation
Bikdeli, Behnood; Khairani, Candrika D; Krishnathasan, Darsiya; Bejjani, Antoine; Armero, Andre; Tristani, Anthony; Davies, Julia; Porio, Nicole; Assi, Ali A; Nauffal, Victor; Campia, Umberto; Almarzooq, Zaid; Wei, Eric; Achanta, Aditya; Jesudasen, Sirus J; Tiu, Bruce C; Merli, Geno J.; Leiva, Orly; Fanikos, John; Sharma, Aditya; Vishnevsky, Alec; Hsia, Judith; Nehler, Mark R; Welker, James; Bonaca, Marc P; Carroll, Brett J; Lan, Zhou; Goldhaber, Samuel Z; and Piazza, Gregory, "Major Cardiovascular Events After COVID-19, Event Rates Post-vaccination, Antiviral or Anti-inflammatory Therapy, and Temporal Trends: Rationale and Methodology of the Corona-VTE-Network Study" (2023). Division of Cardiology Faculty Papers. Paper 132.
https://jdc.jefferson.edu/cardiologyfp/132
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Language
English
PubMed ID
37302267
Comments
This article is the author's final published version in Thrombosis Research, Volume 228, August 2023, Pages 94 - 104.
The published version is available at https://doi.org/10.1016/j.thromres.2023.05.019.
Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/)